|
1
|
Sripa B and Pairojkul C:
Cholangiocarcinoma: Lessons from Thailand. Curr Opin Gastroenterol.
24:349–356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Welzel TM, McGlynn KA, Hsing AW, O'Brien
TR and Pfeiffer RM: Impact of classification of hilar
cholangiocarcinomas (Klatskin tumors) on the incidence of intra-and
extrahepatic cholangiocarcinoma in the United States. J Natl Cancer
Inst. 98:873–875. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
West J, Wood H, Logan R, Quinn M and
Aithal G: Trends in the incidence of primary liver and biliary
tract cancers in England and Wales 1971–2001. Br J Cancer.
94:1751–1758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patt YZ, Hassan MM, Aguayo A, Nooka AK,
Lozano RD, Curley SA, Vauthey JN, Ellis LM, Schnirer II, Wolff RA,
et al: Oral capecitabine for the treatment of hepatocellular
carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer.
101:578–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thongprasert S: The role of chemotherapy
in cholangiocarcinoma. Ann Oncol. 16:ii93–ii96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hahnvajanawong C, Boonyanugomol W,
Nasomyon T, Loilome W, Namwat N, Anantachoke N, Tassaneeyakul W,
Sripa B, Namwat W and Reutrakul V: Apoptotic activity of caged
xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines.
World J Gastroenterol. 16:2235–2243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saralamp P, Chuakul W, Temsiririrkkul R
and Clayton T: Medicinal Plants in Thailand. 1. Amarin Printing and
Publishing Public Co., Ltd.; Bangkok: 1996
|
|
8
|
Wu ZQ, Guo QL, You QD, Zhao L and Gu HY:
Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1
cells in vivo and in vitro and represses telomerase activity and
telomerase reverse transcriptase mRNA expression in the cells. Bio
Pharm Bull. 27:1769–1774. 2004. View Article : Google Scholar
|
|
9
|
Han QB, Wang YL, Yang L, Tso TF, Qiao CF,
Song JZ, Xu LJ, Chen SL, Yang DJ and Xu HX: Cytotoxic
polyprenylated xanthones from the resin of Garcinia hanburyi. Chem
Pharm Bull. 54:265–267. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reutrakul V, Anantachoke N, Pohmakotr M,
Jaipetch T, Sophasan S, Yoosook C, Kasisit J, Napaswat C, Santisuk
T and Tuchinda P: Cytotoxic and anti-HIV-1 caged xanthones from the
resin and fruits of garcinia hanburyi. Planta Med. 73:33–40. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo QL, You QD, Wu ZQ, Yuan ST and Zhao L:
General gambogic acids inhibited growth of human hepatoma SMMC-7721
cells in vitro and in nude mice. Acta Pharmacol Sin. 25:769–774.
2004.PubMed/NCBI
|
|
12
|
Liu W, Guo QL, You QD, Zhao L, Gu HY and
Yuan ST: Anticancer effect and apoptosis induction of gambogic acid
in human gastric cancer line BGC-823. World J Gastroenterol.
11:3655–3659. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao L, Guo QL, You QD, Wu ZQ and Gu HY:
Gambogic acid induces apoptosis and regulates expressions of Bax
and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Bio
Pharm Bull. 27:998–1003. 2004. View Article : Google Scholar
|
|
14
|
Qin Y, Meng L, Hu C, Duan W, Zuo Z, Lin L,
Zhang X and Ding J: Gambogic acid inhibits the catalytic activity
of human topoisomerase IIalpha by binding to its ATPase domain. Mol
Cancer Ther. 6:2429–2440. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu J, Guo QL, You QD, Lin SS, Li Z, Gu HY,
Zhang HW, Tan Z and Wang X: Repression of telomerase reverse
transcriptase mRNA and hTERT promoter by gambogic acid in human
gastric carcinoma cells. Cancer Chemother Pharmacol. 58:434–443.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu J, Guo QL, You QD, Zhao L, Gu HY, Yang
Y, Zhang HW, Tan Z and Wang X: Gambogic acid-induced G2/M phase
cell-cycle arrest via disturbing CDK7-mediated phosphorylation of
CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis.
28:632–638. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pandey MK, Sung B, Ahn KS, Kunnumakkara
AB, Chaturvedi MM and Aggarwal BB: Gambogic acid, a novel ligand
for transferrin receptor, potentiates TNF-induced apoptosis through
modulation of the nuclear factor-KappaB signaling pathway. Blood.
110:3517–3525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo Q, Qi Q, You Q, Gu H, Zhao L and Wu Z:
Toxicological studies of gambogic acid and its potential targets in
experimental animals. Basic Clin Pharmacol Toxicol. 99:178–184.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi Q, You Q, Gu H, Zhao L, Liu W, Lu N and
Guo Q: Studies on the toxicity of gambogic acid in rats. J
Ethnopharmacol. 117:433–438. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qi Q, Gu H, Yang Y, Lu N, Zhao J, Liu W,
Ling H, You QD, Wang X and Guo Q: Involvement of matrix
metalloproteinase 2 and 9 in gambogic acid induced suppression of
MDA-MB-435 human breast carcinoma cell lung metastasis. J Mol Med
(Berl). 86:1367–1377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hahnvajanawong C, Ketnimit S,
Pattanapanyasat K, Anantachoke N, Sripa B, Pinmai K, Seubwai W and
Reutrakul V: Involvement of p53 and nuclear factor-kappaB signaling
pathway for the induction of G1-phase cell cycle arrest of
cholangiocarcinoma cell lines by isomorellin. Bio Pharm Bull.
35:1914–1925. 2012.
|
|
22
|
Hahnvajanawong C, Wattanawongdon W,
Chomvarin C, Anantachoke N, Kanthawong S, Sripa B and Reutrakul V:
Synergistic effects of isomorellin and forbesione with doxorubicin
on apoptosis induction in human cholangiocarcinoma cell lines.
Cancer Cell Int. 14:682014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Puthdee N, Vaeteewoottacharn K, Seubwai W,
Wonkchalee O, Kaewkong W, Juasook A, Pinlaor S, Pairojkul C,
Wongkham C, Okada S, et al: Establishment of an allo-transplantable
hamster cholangiocarcinoma cell line and its application for in
vivo screening of anti-cancer drugs. Korean J Parasitol.
51:711–717. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pinmai K, Chunlaratthanabhorn S,
Ngamkitidechakul C, Soonthornchareon N and Hahnvajanawong C:
Synergistic growth inhibitory effects of Phyllanthus emblica and
Terminalia bellerica extracts with conventional cytotoxic agents:
Doxorubicin and cisplatin against human hepatocellular carcinoma
and lung cancer cells. World J Gastroenterol. 14:1491–1497. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boonmars T, Srisawangwong T, Srirach P,
Kaewsamut B, Pinlaor S and Sithithaworn P: Apoptosis-related gene
expressions in hamsters re-infected with Opisthorchis viverrini and
re-treated with praziquantel. Parasitol Res. 102:57–62. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boonmars T, Wu Z, Nagano I and Takahashi
Y: Expression of apoptosis-related factors in muscles infected with
Trichinella spiralis. Parasitology. 128:323–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y,
Ip C, Onate SA and Gao AC: Selenium disrupts estrogen signaling by
altering estrogen receptor expression and ligand binding in human
breast cancer cells. Cancer Res. 65:3487–3492. 2005.PubMed/NCBI
|
|
29
|
Wu Z, Boonmars T, Nagano I, Boonjaraspinyo
S, Pinlaor S, Pairojkul C, Chamgramol Y and Takahashi Y: Alteration
of galectin-1 during tumorigenesis of Opisthorchis viverrini
infection-induced cholangiocarcinoma and its correlation with
clinicopathology. Tumour Biol. 33:1169–1178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wonkchalee O, Boonmars T, Aromdee C,
Laummaunwai P, Khunkitti W, Vaeteewoottacharn K, Sriraj P,
Aukkanimart R, Loilome W, Chamgramol Y, et al: Anti-inflammatory,
antioxidant and hepatoprotective effects of Thunbergia laurifolia
Linn. on experimental opisthorchiasis. Parasitol Res. 111:353–359.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baskić D, Popović S, Ristić P and
Arsenijević NN: Analysis of cycloheximide-induced apoptosis in
human leukocytes: Fluorescence microscopy using annexin V/propidium
iodide versus acridin orange/ethidium bromide. Cell Biol Int.
30:924–932. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grimm S and Brdiczka D: The permeability
transition pore in cell death. Apoptosis. 12:841–855. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cryns V and Yuan J: Proteases to die for.
Genes Dev. 12:1551–1570. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burlacu A: Regulation of apoptosis by
Bcl-2 family proteins. J Cell Mol Med. 7:249–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Szegezdi E, Logue SE, Gorman AM and Samali
A: Mediators of endoplasmic reticulum stress-induced apoptosis.
EMBO Rep. 7:880–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu J and Kaufman R: From acute ER stress
to physiological roles of the unfolded protein response. Cell Death
Differ. 13:374–384. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guttridge DC, Albanese C, Reuther JY,
Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and
differentiation through transcriptional regulation of cyclin D1.
Mol Cell Biol. 19:5785–5799. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Perkins ND: The Rel/NF-kappa B family:
Friend and foe. Trends Biochem Sci. 25:434–440. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sriraj P, Aukkanimart R, T Juasook A
Boonmars, Sudsarn P, Wonkchalee N, Pairojkul C, Waraasawapati S,
Laummaunwai P and Boonjaraspinyo S: Does a combination of
opisthorchiasis and ethyl alcohol consumption enhance early
cholangiofibrosis, the risk of cholangiocarcinoma? Parasitol Res.
112:2971–2981. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao W, Zhou SF, Zhang ZP, Xu GP, Li XB
and Yan JL: Gambogic acid inhibits the growth of osteosarcoma cells
in vitro by inducing apoptosis and cell cycle arrest. Oncol Rep.
25:1289–1295. 2011.PubMed/NCBI
|
|
42
|
Chen J, Gu HY, Lu N, Yang Y, Liu W, Qi Q,
Rong JJ, Wang XT, You QD and Guo QL: Microtubule depolymerization
and phosphorylation of c-Jun N-terminal kinase-1 and p38 were
involved in gambogic acid induced cell cycle arrest and apoptosis
in human breast carcinoma MCF-7 cells. Life Sci. 83:103–109. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Graña X and Reddy EP: Cell cycle control
in mammalian cells: Role of cyclins, cyclin dependent kinases
(CDKs), growth suppressor genes and cyclin-dependent kinase
inhibitors (CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
|
|
44
|
King K and Cidlowski J: Cell cycle
regulation and apoptosis 1. Annu Rev Physiol. 60:601–617. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yadav V, Sultana S, Yadav J and Saini N:
Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic
cancer cells via p21/p27/p53. PLoS One. 7:e477962012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Maga G and Hubscher U: Proliferating cell
nuclear antigen (PCNA): A dancer with many partners. J Cell Sci.
116:3051–3060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Engel FB, Hauck L, Boehm M, Nabel EG,
Dietz R and von Harsdorf R: P21(CIP1) controls proliferating cell
nuclear antigen level in adult cardiomyocytes. Mol Cell Bio.
23:555–565. 2003. View Article : Google Scholar
|
|
48
|
Steller H: Mechanisms and genes of
cellular suicide. Science. 267:1445–1449. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nagata S: Apoptotic DNA fragmentation. Exp
Cell Res. 256:12–18. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kajstura M, Halicka HD, Pryjma J and
Darzynkiewicz Z: Discontinuous fragmentation of nuclear DNA during
apoptosis revealed by discrete ‘sub-G1’ peaks on DNA content
histograms. Cytometry A. 71:125–131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Franz S, Frey B, Sheriff A, Gaipl US, Beer
A, Voll RE, Kalden JR and Herrmann M: Lectins detect changes of the
glycosylation status of plasma membrane constituents during late
apoptosis. Cytometry A. 69:230–239. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Oberhammer F, Wilson J, Dive C, Morris ID,
Hickman JA, Wakeling AE, Walker PR and Sikorska M: Apoptotic death
in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments
prior to or in the absence of internucleosomal fragmentation. EMBO
J. 12:3679–3984. 1993.PubMed/NCBI
|
|
54
|
Darzynkiewicz Z, Juan G, Li X, Gorczyca W,
Murakami T and Traganos F: Cytometry in cell necrobiology: Analysis
of apoptosis and accidental cell death (necrosis). Cytometry.
27:1–20. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Huang X, Halicka HD, Traganos F, Tanaka T,
Kurose A and Darzynkiewicz Z: Cytometric assessment of DNA damage
in relation to cell cycle phase and apoptosis. Cell Prolif.
38:223–243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jakubikova J, Bao Y and Sedlak J:
Isothiocyanates induce cell cycle arrest, apoptosis and
mitochondrial potential depolarization in HL-60 and
multidrug-resistant cell lines. Anticancer Res. 25:3375–3386.
2005.PubMed/NCBI
|
|
57
|
Du Y, Wang K, Fang H, Li J, Xiao D, Zheng
P, Chen Y, Fan H, Pan X, Zhao C, Zhang Q, et al: Coordination of
intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis
by imatinib mesylate combined with arsenic trioxide in chronic
myeloid leukemia. Blood. 107:1582–1590. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Choi C and Benveniste EN: Fas ligand/Fas
system in the brain: Regulator of immune and apoptotic responses.
Brain Res Rev. 44:65–81. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chatfield K and Eastman A: Inhibitors of
protein phosphatases 1 and 2A differentially prevent intrinsic and
extrinsic apoptosis pathways. Biochem Biophys Res Commun.
323:1313–1320. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liang X, Wu A, Xu Y, Xu K, Liu J and Qian
X: B1, a novel naphthalimide-based DNA intercalator, induces cell
cycle arrest and apoptosis in HeLa cells via p53 activation. Invest
New Drugs. 29:646–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fulda S and Debatin K: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Deveraux QL and Reed JC: IAP family
proteins-suppressors of apoptosis. Genes Dev. 13:239–252. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC,
Hwang JI, Chung CW, Jung YK and Oh BH: An anti-apoptotic protein
human survivin is a direct inhibitor of caspase-3 and-7.
Biochemistry. 40:1117–1123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Baldwin AS Jr: The NF-kappaB and I kappaB
proteins: New discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ghosh S and Karin M: Missing pieces in the
NF-kappaB puzzle. Cell. 109:(Suppl). S81–S96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hsia CY, Cheng S, Owyang AM, Dowdy SF and
Liou HC: C-Rel regulation of the cell cycle in primary mouse B
lymphocytes. Int Immunol. 14:905–916. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tracey L, Perez-Rosado A, Artiga MJ,
Pérez-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N,
Ruiz-Ballesteros E, Mollejo M, et al: Expression of the NF-kappaB
targets BCL2 and BIRC5/Survivin characterizes small B-cell and
aggressive B-cell lymphomas, respectively. J Pathol. 206:123–134.
2005. View Article : Google Scholar : PubMed/NCBI
|
